Healthy Swimming: Prevent and Treat Infections Caused by Brain-Eating Amebas and Chlorine-Tolerant Parasites

Presenter(s)

Overview

Swimming and other water-related activities are popular during the summer. However, Naegleria fowleri, known as the brain-eating ameba, may be present in warm freshwater and can result in primary amebic meningoencephalitis (PAM) – a rare disease that is almost always fatal. Additionally, the chlorine-tolerant parasite Cryptosporidium, is one of the most frequent causes of waterborne disease among humans in the United States. During this COCA call, clinicians will learn about PAM and diarrhea resulting from Cryptosporidium, how to prevent these diseases, and what to do if you suspect your patient has one of them.

Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

• Describe the epidemiology, clinical features, diagnostic testing, and treatments available
• Discuss the steps that can be taken to prevent PAM and cryptosporidiosis
• State the protocol for contacting CDC to obtain clinical consultation, diagnostic testing, and the investigative drug miltefosine for treatment of PAM caused by Naegleria fowleri

Call Materials

• Slides:View Now
• Webcast:Watch Now
• Audio:Listen Now
• Transcript:Read Now

Additional Resources

• CDC Naegleria: Information for Public Health & Medical Professionals
• CDC Cryptosporidium: Resources for Health Professionals
• CDC Healthy Swimming
• CDC Healthy Water

Call Format

• Live webcasts and audio conference call 6/19/2014: 2:00 - 3:00 PM
• Web-on-demand training after 4:00 PM on 6/19/2014

Additional Call Information

Accreditation Statements

CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME^®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 1.0 contact hour.

IACET CEU:The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 0.1 ANSI/IACET CEU's for this program.

CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082.

CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 Contact Hour in pharmacy education. The Universal Activity Number is 0387-0000-14-103-L04-P and enduring 0387-0000-14-103-H04-P course category.

This program is  knowledge based.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE:In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.